Paper33210341
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis.
Jiang Y and 4 others. Cell Prolif, 2021. Cited by 202 papers, by iCite.
Cite this record
ConductScience Library. Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Papers, record 33210341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33210341
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cell Transplantation | Major topic |
| Osteoporosis | Major topic |
| Animals | |
| Humans | |
| Mesenchymal Stem Cells |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 7192228 | Natural Science Foundation of Beijing Municipality | PubMed | ||
| L182006 | Natural Science Foundation of Beijing Municipality | PubMed |
Source PubMed
References164
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10869556 | Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). | FEBS Lett | 2000 | https://conductscience.org/library/papers/10869556 | PubMed |
| 2 | 12456962 | Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. | Stem Cells | 2002 | https://conductscience.org/library/papers/12456962 | PubMed |
| 3 | 23734780 | Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. | Stem Cell Res Ther | 2013 | https://conductscience.org/library/papers/23734780 | PubMed |
| 4 | 22539160 | Improvement of intertrochanteric bone quality in osteoporotic female rats after injection of polylactic acid-polyglycolic acid copolymer/collagen type I microspheres combined with bone mesenchymal stem cells. | Int Orthop | 2012 | https://conductscience.org/library/papers/22539160 | PubMed |
| 5 | 27083447 | BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27083447 | PubMed |
| 6 | 16889506 | Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. | Tissue Eng | 2006 | https://conductscience.org/library/papers/16889506 | PubMed |
| 7 | 29949171 | Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway. | Eur Rev Med Pharmacol Sci | 2018 | https://conductscience.org/library/papers/29949171 | PubMed |
| 8 | 29208188 | The antiosteoporosis effect of icariin in ovariectomized rats: a systematic review and meta-analysis. | Cell Mol Biol (Noisy-le-grand) | 2017 | https://conductscience.org/library/papers/29208188 | PubMed |
| 9 | 29348535 | Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats. | Sci Rep | 2018 | https://conductscience.org/library/papers/29348535 | PubMed |
| 10 | 29370110 | Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29370110 | PubMed |
| 11 | 17067463 | [A study on repairing mandibular defect by means of tissue-engineering and human bone morphogenetic protein-2 gene transfection in osteoporotic rats]. | Zhonghua Kou Qiang Yi Xue Za Zhi | 2006 | https://conductscience.org/library/papers/17067463 | PubMed |
| 12 | 20167120 | Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. | Arthritis Res Ther | 2010 | https://conductscience.org/library/papers/20167120 | PubMed |
| 13 | 16556708 | Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. | Stem Cells | 2006 | https://conductscience.org/library/papers/16556708 | PubMed |
| 14 | 18407820 | Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. | Bone | 2008 | https://conductscience.org/library/papers/18407820 | PubMed |
| 15 | 29562774 | Xenograft of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly Differentiating into Osteocytes and Reducing Osteoclast Activity Reverses Osteoporosis in Ovariectomized Rats. | Cell Transplant | 2018 | https://conductscience.org/library/papers/29562774 | PubMed |
| 16 | 24816446 | Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine. | Cell Transplant | 2014 | https://conductscience.org/library/papers/24816446 | PubMed |
| 17 | 29495518 | Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients. | Nutrients | 2018 | https://conductscience.org/library/papers/29495518 | PubMed |
| 18 | 21627784 | Bone regeneration: current concepts and future directions. | BMC Med | 2011 | https://conductscience.org/library/papers/21627784 | PubMed |
| 19 | 17088434 | Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. | J Exp Med | 2006 | https://conductscience.org/library/papers/17088434 | PubMed |
| 20 | 18638562 | Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. | Cell Biol Int | 2008 | https://conductscience.org/library/papers/18638562 | PubMed |
Cited by157
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939567 | Therapeutic Potential of Hydrogen Sulfide in Bone Deficiency. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939567 | PubMed |
| 42928910 | Bone quality deterioration is accompanied by mesenchymal stem cell defects in osteoporosis patients undergoing spinal fusion. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42928910 | PubMed |
| 42881481 | Mn/Zn Bimetallic MOF-Integrated Hydrogel Alleviates Excessive Mitochondrial Fission in BMSCs to Promote Osteoporotic Jawbone Repair. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42881481 | PubMed |
| 42496813 | The Role of Short-Chain Fatty Acids and Derived Metabolites in Osteoporosis. | Curr Osteoporos Rep | 2026 | https://conductscience.org/library/papers/42496813 | PubMed |
| 42462727 | Functional matrix vesicle replacement partially restores chemo-mechanical coupling in the aged bone niche. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42462727 | PubMed |
| 42381138 | A Review of the Mechanisms, Biological Basis, and Active Ingredients of Traditional Chinese Medicine Formulations in Regulating Organ Function to Alleviate Osteoporosis. | Endocr Metab Immune Disord Drug Targets | 2026 | https://conductscience.org/library/papers/42381138 | PubMed |
| 42228211 | ABCA8 drives bone loss via disrupting Th17/Treg imbalance: a novel immunometabolic target for osteoporosis. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42228211 | PubMed |
| 42222165 | Mitigating mitochondrial dysfunction: a novel strategy for Chinese botanical drugs against osteoporosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42222165 | PubMed |
| 42181171 | Stage-specific biomimetic nanoparticles reprogram osteoblast-adipocyte equilibrium for targeted osteoporosis therapy. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42181171 | PubMed |
| 41993718 | Genetically reprogrammed BMSCs with Lamin B1 depletion enhance bone regeneration for osteoporosis therapy. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41993718 | PubMed |
| 41953858 | Micro/Nanoparticles in the Nose-Brain Axis: Implications for Pathogenesis and Therapeutic Interventions. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41953858 | PubMed |
| 41843192 | Morinda officinalis polysaccharide improves osteoporosis by enhancing m⁶A-modified SOCS5 mRNA stability via regulating the hsa_circ_0001165/IGF2BP2 axis. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/41843192 | PubMed |
| 41793557 | Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41793557 | PubMed |
| 41764760 | Targeting the STK39/ARID2 Axis to Inhibit NF-κB Signaling: A Novel Pathway for Mesenchymal Stem Cell Osteogenic Differentiation in Osteoporosis Management. | J Musculoskelet Neuronal Interact | 2026 | https://conductscience.org/library/papers/41764760 | PubMed |
| 41715169 | In situ electrospinning at the operating table to immobilise mesenchymal stem cells on the bony wall for the regeneration of osteoporotic bone defects. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41715169 | PubMed |
| 41480394 | Optimizing mesenchymal stem cell therapy for tendon-bone healing: Multifaceted approaches and future directions. | World J Stem Cells | 2025 | https://conductscience.org/library/papers/41480394 | PubMed |
| 41390652 | Apoptotic vesicles rectify senile bone-fat imbalance by activating Thy1-ERK-TAZ axis. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41390652 | PubMed |
| 41327200 | Delivery of miR-29a/29c-3p by serum exosomes promotes osteogenesis through TET3-dependent Sox9 demethylation and PI3K/Akt activation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41327200 | PubMed |
| 41253275 | IRF1 regulates apoptosis and osteogenic differentiation of bone marrow mesenchymal stem cells and ameliorates osteoporosis by activating the PI3K/AKT signaling pathway. | J Adv Res | 2026 | https://conductscience.org/library/papers/41253275 | PubMed |
| 41174641 | Functionalized mesenchymal stem cells for enhanced bone regeneration: advances and challenges. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41174641 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33210341
GET https://conductscience.org/api/papers/v1/33210341/references?page=2